# Project State (updated Session 56, 2026-03-26)

## Current Phase
- Phase 1-6: ALL COMPLETE
- Phase 7 Specs A+C+B: COMPLETE (Session 56, PRs #102-104)
- Phase 7 Spec D (Health Materialization): NEXT — KAN-161

## Session 56 Summary
Phase 7 implementation — 3 specs shipped in one session:
- KAN-158 Guardrails: guards.py, input/output guards, PII, injection, disclaimer, decline_count (migration 013). 32 new tests. PR #102.
- KAN-159 Data Enrichment: beta/yield/PE on Stock (migration 014), news.py (defusedxml), intelligence.py, 2 API endpoints. 16 new tests. PR #103.
- KAN-160 Agent Intelligence: 4 new tools (portfolio_health, market_briefing, get_stock_intelligence, recommend_stocks), planner response_type, 2 API endpoints. 28 new tests. PR #104.
Portfolio health schemas split from infra health.py into portfolio_health.py.

## Resume Point
KAN-161 (Health Materialization) — last spec in Phase 7. Depends on KAN-160 (done).
Then: backlog items KAN-149-157.

## Stats
- 806 unit tests passing (+72 new this session)
- 24 internal tools (was 20) + 12 MCP adapters = 36 total
- Alembic head: migration 014 (beta/yield/PE)
- Migrations: 012 (LLM config) -> 013 (decline_count) -> 014 (beta/yield/PE)

## Open Bugs
- None
